Divis Laboratories share price has plunged 3% and is presently trading at Rs 4,697.9.
Meanwhile, the BSE HEALTHCARE index is at 41,002.0 (down 0.1%).
Among the top losers in the BSE HEALTHCARE index today are Biocon (down 2.5%) and CAPLIN POINT (down 2.1%).
APOLLO HOSPITALS (up 3.5%) and AJANTA PHARMA (up 1.9%) are among the top gainers today.
Over the last one year, Divis Laboratories has moved up from Rs 3,731.4 to Rs 4,697.9, registering a gain of Rs 966.5 (up 25.9%).
On the other hand, the BSE HEALTHCARE index has moved up from 27,819.2 to 41,002.0, registering a gain of 47.4% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were GRANULES INDIA (up 129.7%), GSK Pharma (up 100.6%) and Jubilant Pharmova (up 97.6%).
Dear Reader: If You Invest in Midcap Stocks, this is for You
The BSE Sensex is at 79,034.1 (up 0.1%).
The top gainers among the BSE Sensex today are TCS (up 2.3%) and Tech Mahindra (up 1.4%). The most traded stocks in the BSE Sensex are Tata Steel and Infosys.
In the meantime, NSE Nifty is at 24,140.9 . APOLLO HOSPITALS and TCS are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 65,401.9 to 79,034.1, registering a gain of 13,632.2 points (up 20.8%).
Divis Laboratories net profit grew 20.8% YoY to Rs 4,300 million for the quarter ended June 2024, compared to a profit of Rs 3,560 million a year ago. Net sales rose 19.1% to Rs 21,180 million during the period as against Rs 17,780 million in April-June 2023.
For the year ended March 2024, Divis Laboratories reported 12.3% decrease in net profit to Rs 16,000 million compared to net profit of Rs 18,240 million during FY23. Revenue of the company grew 1.0% to Rs 78,450 million during FY24.
The current Price to earnings ratio of Divis Laboratories, based on rolling 12 month earnings, stands at 74.5.
Equitymaster requests your view! Post a comment on "Divis Laboratories Plunges 3%; BSE HEALTHCARE Index Down 0.1%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!